Award
NIH Reporter #5R01DK118267-07
Nucleophosmin Centered Diagnostics and Treatment of Ischemic Acute Kidney Injury
Recipient
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Award Amount
$555,038.00
Ceiling
$555,038.00
Awarded
March 24, 2026
Identifier
5R01DK118267-07
NIH grant awarded for research on Nucleophosmin and Bax to develop treatments for ischemic acute kidney injury, including structural analysis and pre-clinical testing.
Description
This is a NIH grant project focused on the structure-function relationship of NPM and Bax to develop therapeutics for ischemic AKI. The project involves structural analysis, peptide optimization, and pre-clinical testing.